(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/content-delivery-solution.jpg

Our content delivery solution through CRWE WORLDCRWE Press Release and CRWE Tubegives corporations and businesses a vehicle to expand their exposure

Content Delivery Solution (Learn More)

ad3

https://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

https://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business

www.CRWEPressRelease.com






10 Result: Nasdaq:AMD

Earnings On The Horizon: Microsoft, AMD, and Danaher - A Preview

January 28th, 2024

On Tuesday, January 30, major players in the business landscape are set to unveil their financial results, including: Microsoft Corporation (Nasdaq: MSFT), the tech giant, will disclose its second-quarter fiscal 2024 earnings after the market clos. Read more

Tonix Pharma's TNX-601 ER Trial Misses Endpoint; AMD Posts Upbeat Results

November 01st, 2023

Shares of Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) experienced a drastic over 20% decline in after-hours trading following the release of Phase 2 proof-of-concept study results for TNX-601 ER, intended for patients with major depressive dis. Read more

Upcoming Earnings: AMD, BP, and JetBlue Airways in Focus

October 28th, 2023

On Tuesday, October 31, a lineup of companies is slated to unveil their financial results, including: Advanced Micro Devices, Inc. (Nasdaq: AMD), a notable semiconductor company, will report its fiscal third quarter 2023 financial results after th. Read more

Q2 2023 Earnings: Terex and AMD Outperform Expectations

August 01st, 2023

Terex Corporation (NYSE: TEX) delivered strong second-quarter 2023 financial results, with earnings per share (EPS) of $2.35 and revenues of $1.40 billion, surpassing the consensus estimate of $1.66 on revenues of $1.27 billion. Buoyed by its stro. Read more

Earnings On The Horizon: Merck, Pfizer, AMD, and Caterpillar - A Preview

July 28th, 2023

Multiple companies are set to report their financial results on Tuesday, August 1, including: Merck & Co., Inc. (NYSE: MRK), a pharmaceutical giant, is expected to announce its second-quarter 2023 earnings results prior to the market opening. . Read more

Breaking Updates: JetBlue, Spirit Airlines, Deckers Outdoor, and AMD in Focus

July 05th, 2023

JetBlue Airways Corporation (Nasdaq: JBLU) has decided to terminate its Northeast Alliance (NEA) with American Airlines following a court ruling. The company will now shift its focus to a proposed combination with Spirit Airlines, Inc. (NYSE: SAVE), . Read more

UK's CMA OKs Amazon's iRobot Purchase; Morgan Stanley PT Boosts NVIDIA, AMD, Adobe, Intel, Marvell

June 16th, 2023

The Competition and Markets Authority (CMA) in the UK has cleared Amazon.com, Inc.'s (Nasdaq: AMZN) $1.7 billion purchase of iRobot Corporation (Nasdaq: IRBT), the maker of Roomba robot vacuum cleaners.  The CMA examined potential concerns re. Read more

Analysts See Bullishness for AMD; AMMO Beats Wall Street Estimates

June 14th, 2023

Advanced Micro Devices, Inc. (Nasdaq: AMD), a leading technology company in the semiconductor industry, has garnered positive evaluations and price target increases from various reputable financial institutions. The following institutions maintain. Read more

Keybanc Sees Opportunity On AMD, AppFolio, AvidXchange, and Ameren

June 12th, 2023

Advanced Micro Devices, Inc. (Nasdaq: AMD), a leading semiconductor company specializing in advanced computing and graphics technologies, saw its price target raised by KeyBanc from $110 to $150.  With $AMD closing at $124.92 on Friday, this . Read more

Hoth Therapeutics, AMD, Agenus, Vale, Airbnb, Stem: Biotech News, Bullish Views

June 06th, 2023

Hoth Therapeutics, Inc. (Nasdaq: HOTH) shared promising news regarding HT-ALZ, their therapeutic under development for Alzheimer's disease.  Positive preclinical results surpassed their previous study, with the higher dose showing the most be. Read more

Load More Content